Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Surgical Pathology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Parathyroid carcinoma: an update on treatment outcomes and prognostic factors from the national cancer data base (NCDB).Ann Surg Oncol. 2015; 22: 3990-3995
- Parathyroid cancer: a review.Cancers. 2019; 11: 1676
- Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.Hum Mutat. 2017; 38: 1621-1648
- WHO classification of Tumours of endocrine organs. 4th edition. International Agency for Research on Cancer, Lyon, France2017
- Overview of the 2022 WHO Classification of Parathyroid Tumors.Endocr Pathol. 2022; 33: 64-89
- Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features.Am J Surg Pathol. 2019; 43: 35-46
- Negative Parafibromin Staining Predicts Malignant Behavior in Atypical Parathyroid Adenomas.Ann Surg Oncol. 2014; 21: 426-433
- Loss of Nuclear Expression of Parafibromin Distinguishes Parathyroid Carcinomas and Hyperparathyroidism-Jaw Tumor (HPT-JT) Syndrome-related Adenomas From Sporadic Parathyroid Adenomas and Hyperplasias.Am J Surg Pathol. 2006; : 1140-1149https://doi.org/10.1097/01.pas.0000209827.39477.4f
- Hereditary Parathyroid Disease: Sometimes Pathologists Do Not Know What They Are Missing.Endocr Pathol. 2020; 31: 218-230
- Hyperparathyroidism jaw tumour syndrome: a pictoral review.Insights Imaging. 2016; 7: 793-800
- HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome.Nat Genet. 2002; 32: 676-680
- Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism–jaw tumor syndrome.Endocr Relat Cancer. 2010; 17: 513-524
- Characterization of a New CDC73 Missense Mutation that Impairs Parafibromin Expression and Nucleolar Localization.PLoS ONE. 2014; 9: e97994
- HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours.J Med Genet. 2003; 40: 657-663
- Somatic and Germ-Line Mutations of the HRPT2 Gene in Sporadic Parathyroid Carcinoma.N Engl J Med. 2003; 349: 1722-1729
- CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer.Endocr Connect. 2013; 2: 186-195
- Understanding the Genetic Basis of Parathyroid Carcinoma.Endocr Pathol. 2014; 25: 30-34
- Molecular pathogenesis of parathyroid tumours.Best Pract Res Clin Endocrinol Metab. 2018; 32: 891-908
- Loss of parafibromin expression in a subset of parathyroid adenomas.Endocr Relat Cancer. 2006; 13: 509-523
- Prognostic role of parafibromin staining and CDC73 mutation in patients with parathyroid carcinoma: A systematic review and meta-analysis based on individual patient data.Clin Endocrinol (Oxf). 2020; 92: 295-302
- Diagnostic and prognostic implications of parafibromin immunohistochemistry in parathyroid carcinomaT.Biosci Rep. 2019; 39 (BSR20181778)
- Diagnostic performance of parafibromin immunohistochemical staining for sporadic parathyroid carcinoma: a meta-analysis.Endocrine. 2016; 54: 612-619
- The Influence of Surgical Extent and Parafibromin Staining on The Outcome of Parathyroid Carcinoma: 20-Year Experience From a Single Institute.Endocr Pract. 2019; 25: 634-641
- Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma.Mod Pathol. 2011; 24: 688-697
- Loss of Parafibromin Immunoreactivity Is a Distinguishing Feature of Parathyroid Carcinoma.Clin Cancer Res. 2004; 10: 6629-6637
- Novel HRPT2/CDC73 Gene Mutations and Loss of Expression of Parafibromin in Chinese Patients with Clinically Sporadic Parathyroid Carcinomas.PLoS ONE. 2012; 7: e45567
- CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort.Cell Oncol. 2012; 35: 411-422
- New and Emerging Biomarkers in Endocrine Pathology.Adv Anat Pathol. 2019; 26: 198-209
- Alterations of DNA methylation in parathyroid tumors.Mol Cell Endocrinol. 2018; 469: 60-69
- CDC73/HRPT2 CpG island hypermethylation and mutation of 5′-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors.Endocr Relat Cancer. 2010; 17: 273-282
- Parafibromin immunostainings of parathyroid tumors in clinical routine: a near-decade experience from a tertiary center.Mod Pathol. 2019; 32: 1082-1094
- Using a Novel Diagnostic Nomogram to Differentiate Malignant from Benign Parathyroid Neoplasms.Endocr Pathol. 2019; 30: 285-296
- Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malignant tumours.Virchows Arch. 2011; 459: 47-53
- Nucleolar localization of parafibromin is mediated by three nucleolar localization signals.FEBS Lett. 2007; 581: 5070-5074
- A nationwide study on parathyroid carcinoma.Acta Oncol. 2017; 56: 991-1003
- Clinical Features, Treatment, and Surveillance of Hyperparathyroidism-Jaw Tumor Syndrome: An Up-to-Date and Review of the Literature.Int J Endocrinol. 2019; 2019: 1-8
- Case 32-2021: A 14-Year-Old Girl with Swelling of the Jaw and Hypercalcemia.N Engl J Med. 2021; 385: 1604-1613
- Parathyroid Pathology.Surg Pathol Clin. 2019; 12: 1007-1019
- The Clinicopathological Spectrum of Parathyroid Carcinoma.Front Endocrinol. 2019; 10: 731
- Parathyroid Carcinoma: A 43-Year Outcome and Survival Analysis.J Clin Endocrinol Metab. 2011; 96: 3679-3686
- Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors.Endocr Relat Cancer. 2019; 26: R441-R464
- Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations.Surgery. 2008; 143: 630-640
Article info
Publication history
Published online: December 09, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
